Linked Life Data

8933839

Source:http://linkedlifedata.com/resource/pubmed/id/8933839

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1997-2-13
pubmed:abstractText
Eighty-eight patients out of 396 were treated for advanced ovarian cancer first by some cycles of chemotherapy--neoadjuvant chemotherapy-- and after by surgery. An improvement in the quality of surgery and disease-free period was observed while survival rate did not improve, compared with the patients treated by surgery before chemotherapy. It should be stressed that neoadjuvant chemotherapy was applied only in very advanced PS Figo stages. The results are the same in the three studied decades: even in the last one, when cases were selected following new protocols. In our case series all patients after chemotherapy underwent surgery and not only those with partial or complete response to chemotherapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0392-2936
pubmed:author
pubmed:issnType
Print
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
393-6
pubmed:dateRevised
2006-4-24
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
Neoadjuvant chemotherapy in advanced ovarian cancer.
pubmed:affiliation
Gynaecologic Oncology Department, University of Padua, Italy.
pubmed:publicationType
Journal Article